Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis
Journal of Neonatal-Perinatal Medicine · 2024
DOI: 10.3233/npm-230177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neonatal-Perinatal Medicine, 2024. Verfasst von T Le und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious, Placenta, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Our objectives were to determine 1) the prevalence and description of placental pathologic lesions in pregnancies complicated by SARS-CoV-2 infection compared to healthy controls and 2) whether the prevalence and/ or pattern of placental pathologic lesions differed in the few neonates who tested positive for SARS-CoV-2 in the first 48 hours of life at a busy urban county hospital. METHODS: This study included all pregnant mothers who tested positive for SARS-CoV-2 and delivered at our institution from March 2020 to June 2021, while control placentas were collected from term pregnancies without complications. RESULTS: Approximately 90% (n = 380/425) of placentas from pregnancies complicated by SARS-CoV-2 infections had placental pathologic lesions, compared to 32% (n = 16/50) of controls. The predominant lesions were acute histologic chorioamnionitis with or without fetal response (n = 209/380, 55%), maternal vascular malperfusion (n = 180/380, 47%), and other inflammatory lesions (n = 148/380, 39%). Only 14 (2.5%) infants tested positive for SARS-CoV-2 within the first 48 hours of life. There were no significant differences in placental histopathology between infants who tested positive vs. those that were negative for SARS-CoV-2. Placental lesions in mothers who tested positive for SARS-CoV-2 during the first vs. second vs. third pregnancy trimesters, were significantly different in the incidence of inflammatory placental pathologic lesions (n = 9/19, 53% vs. n = 37/98, 49% vs. n = 102/439, 31%, respectively; p < 0.01). CONCLUSION: A significant proportion of women with SARS-CoV-2 infection during pregnancy at a single county hospital have inflammatory and vascular placental lesions at birth, raising questions regarding their downstream effects and clinical consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Parkland Health and Hospital System, Dallas, TX, USA.
Zitieren
APA
Le, T., Lee, D., Brown, L. S., Payton, B. W., Sepulveda, P., Sisman, J., Leon, R. L., Chalak, L. F., & Mir, I. N. (2024). Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.3233/npm-230177
Vancouver
Le T, Lee D, Brown LS, Payton BW, Sepulveda P, Sisman J, et al. Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis. Journal of Neonatal-Perinatal Medicine. 2024. doi:10.3233/npm-230177
BibTeX
@article{Le2024,
author = {Le, T and Lee, D and Brown, L S and Payton, B W and Sepulveda, P and Sisman, J and Leon, R L and Chalak, L F and Mir, I N},
title = {Placental pathology in SARS-CoV-2 infected pregnancies: A single-institution retrospective cohort analysis},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2024},
doi = {10.3233/npm-230177}
}
EUVIMED